Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population
Tumor necrosis factor alpha (TNF-alpha) and its receptors (TNFRI and TNFRII) which exist in soluble form as a product of cleavage of the extracellular domain of membrane integrated receptors, still rise debate about their importance. It was reported that TNF-alpha has numerous actions in diseases su...
Gespeichert in:
| Veröffentlicht in: | Pflügers Archiv 2000, Vol.440 (5 Suppl), p.R61-R063 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | R063 |
|---|---|
| container_issue | 5 Suppl |
| container_start_page | R61 |
| container_title | Pflügers Archiv |
| container_volume | 440 |
| creator | Galvani, V Pretnar Hartman, K Rupreht, R R Novaković, S Stabuc, B Ocvirk, J Menart, V Gaberc Porekar, V Stalc, A Rozman, P Curin Serbec, V |
| description | Tumor necrosis factor alpha (TNF-alpha) and its receptors (TNFRI and TNFRII) which exist in soluble form as a product of cleavage of the extracellular domain of membrane integrated receptors, still rise debate about their importance. It was reported that TNF-alpha has numerous actions in diseases such as inflammation, autoimmunity, infectious diseases, septic shock and many types of cancer [1, 2]. Several authors have reported the significance of sTNFRI level in serum of cancer patients [3, 4]. This study was performed in collaboration with the Institute of Oncology of Slovenia. At least two different mouse monoclonal antibodies (MAbs) against human sTNFRI have been prepared to obtain a sensitive and reliable sandwich ELISA. It was compared with commercially available R&D and Endogen ELISAs for the determination of sTNFRI. Groups of patients with different stages of melanoma and epithelial ovarian carcinoma were tested and their clinical records were reexamined. Levels of sTNFRI were measured and compared with the normal serum levels of sTNFRI. |
| doi_str_mv | 10.1007/s004240000007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72293627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1859471248</sourcerecordid><originalsourceid>FETCH-LOGICAL-c270t-ae6819f7c90aaa50108ec8f50049ab13f66d860dfd98970253aea50dd4ab57713</originalsourceid><addsrcrecordid>eNqNkU1LxDAQhoMo7rp69Co5yXqo5qtJepTF1QVRcNdzSdOpVNqmNq3gvzd1V8SLmEsyk2deZuZF6JSSS0qIuvKECCbI11F7aEoFZxEjlO-jKSGcRlJJPUFH3r8GggnNDtGEhtJYUjFFfu2qIasA90PtOtyA7ZwvPS6M7UPcgYV2fKzw3G8elk-rC2w8Nrjt3EvjfF_ab7RscA2VaVwdfk1fQtP7Mbmu3Ds0gFvXDlXIu-YYHRSm8nCyu2foeXmzWdxF94-3q8X1fWSZIn1kQGqaFMomxBgTE0o0WF3EYeDEZJQXUuZakrzIE50owmJuIGB5LkwWK0X5DJ1vdUOzbwP4Pq1Lb6EKTYIbfKoYS7hkKoDzP0Gq40QoGpb3H5QpTYUQAY226LhS30GRtl1Zm-4jpSQdvUt_eRf4s530kNWQ_9A7s_gnrQiTZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852781444</pqid></control><display><type>article</type><title>Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Galvani, V ; Pretnar Hartman, K ; Rupreht, R R ; Novaković, S ; Stabuc, B ; Ocvirk, J ; Menart, V ; Gaberc Porekar, V ; Stalc, A ; Rozman, P ; Curin Serbec, V</creator><creatorcontrib>Galvani, V ; Pretnar Hartman, K ; Rupreht, R R ; Novaković, S ; Stabuc, B ; Ocvirk, J ; Menart, V ; Gaberc Porekar, V ; Stalc, A ; Rozman, P ; Curin Serbec, V</creatorcontrib><description>Tumor necrosis factor alpha (TNF-alpha) and its receptors (TNFRI and TNFRII) which exist in soluble form as a product of cleavage of the extracellular domain of membrane integrated receptors, still rise debate about their importance. It was reported that TNF-alpha has numerous actions in diseases such as inflammation, autoimmunity, infectious diseases, septic shock and many types of cancer [1, 2]. Several authors have reported the significance of sTNFRI level in serum of cancer patients [3, 4]. This study was performed in collaboration with the Institute of Oncology of Slovenia. At least two different mouse monoclonal antibodies (MAbs) against human sTNFRI have been prepared to obtain a sensitive and reliable sandwich ELISA. It was compared with commercially available R&D and Endogen ELISAs for the determination of sTNFRI. Groups of patients with different stages of melanoma and epithelial ovarian carcinoma were tested and their clinical records were reexamined. Levels of sTNFRI were measured and compared with the normal serum levels of sTNFRI.</description><identifier>ISSN: 0031-6768</identifier><identifier>EISSN: 1432-2013</identifier><identifier>DOI: 10.1007/s004240000007</identifier><identifier>PMID: 11005614</identifier><language>eng</language><publisher>Germany</publisher><subject>Antigens, CD - metabolism ; Carcinoma - metabolism ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Melanoma - metabolism ; Melanoma - secondary ; Ovarian Neoplasms - metabolism ; Prognosis ; Receptors, Tumor Necrosis Factor - metabolism ; Receptors, Tumor Necrosis Factor, Type I ; Slovenia ; Solubility</subject><ispartof>Pflügers Archiv, 2000, Vol.440 (5 Suppl), p.R61-R063</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c270t-ae6819f7c90aaa50108ec8f50049ab13f66d860dfd98970253aea50dd4ab57713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11005614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Galvani, V</creatorcontrib><creatorcontrib>Pretnar Hartman, K</creatorcontrib><creatorcontrib>Rupreht, R R</creatorcontrib><creatorcontrib>Novaković, S</creatorcontrib><creatorcontrib>Stabuc, B</creatorcontrib><creatorcontrib>Ocvirk, J</creatorcontrib><creatorcontrib>Menart, V</creatorcontrib><creatorcontrib>Gaberc Porekar, V</creatorcontrib><creatorcontrib>Stalc, A</creatorcontrib><creatorcontrib>Rozman, P</creatorcontrib><creatorcontrib>Curin Serbec, V</creatorcontrib><title>Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population</title><title>Pflügers Archiv</title><addtitle>Pflugers Arch</addtitle><description>Tumor necrosis factor alpha (TNF-alpha) and its receptors (TNFRI and TNFRII) which exist in soluble form as a product of cleavage of the extracellular domain of membrane integrated receptors, still rise debate about their importance. It was reported that TNF-alpha has numerous actions in diseases such as inflammation, autoimmunity, infectious diseases, septic shock and many types of cancer [1, 2]. Several authors have reported the significance of sTNFRI level in serum of cancer patients [3, 4]. This study was performed in collaboration with the Institute of Oncology of Slovenia. At least two different mouse monoclonal antibodies (MAbs) against human sTNFRI have been prepared to obtain a sensitive and reliable sandwich ELISA. It was compared with commercially available R&D and Endogen ELISAs for the determination of sTNFRI. Groups of patients with different stages of melanoma and epithelial ovarian carcinoma were tested and their clinical records were reexamined. Levels of sTNFRI were measured and compared with the normal serum levels of sTNFRI.</description><subject>Antigens, CD - metabolism</subject><subject>Carcinoma - metabolism</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - secondary</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Prognosis</subject><subject>Receptors, Tumor Necrosis Factor - metabolism</subject><subject>Receptors, Tumor Necrosis Factor, Type I</subject><subject>Slovenia</subject><subject>Solubility</subject><issn>0031-6768</issn><issn>1432-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1LxDAQhoMo7rp69Co5yXqo5qtJepTF1QVRcNdzSdOpVNqmNq3gvzd1V8SLmEsyk2deZuZF6JSSS0qIuvKECCbI11F7aEoFZxEjlO-jKSGcRlJJPUFH3r8GggnNDtGEhtJYUjFFfu2qIasA90PtOtyA7ZwvPS6M7UPcgYV2fKzw3G8elk-rC2w8Nrjt3EvjfF_ab7RscA2VaVwdfk1fQtP7Mbmu3Ds0gFvXDlXIu-YYHRSm8nCyu2foeXmzWdxF94-3q8X1fWSZIn1kQGqaFMomxBgTE0o0WF3EYeDEZJQXUuZakrzIE50owmJuIGB5LkwWK0X5DJ1vdUOzbwP4Pq1Lb6EKTYIbfKoYS7hkKoDzP0Gq40QoGpb3H5QpTYUQAY226LhS30GRtl1Zm-4jpSQdvUt_eRf4s530kNWQ_9A7s_gnrQiTZQ</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Galvani, V</creator><creator>Pretnar Hartman, K</creator><creator>Rupreht, R R</creator><creator>Novaković, S</creator><creator>Stabuc, B</creator><creator>Ocvirk, J</creator><creator>Menart, V</creator><creator>Gaberc Porekar, V</creator><creator>Stalc, A</creator><creator>Rozman, P</creator><creator>Curin Serbec, V</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QP</scope></search><sort><creationdate>2000</creationdate><title>Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population</title><author>Galvani, V ; Pretnar Hartman, K ; Rupreht, R R ; Novaković, S ; Stabuc, B ; Ocvirk, J ; Menart, V ; Gaberc Porekar, V ; Stalc, A ; Rozman, P ; Curin Serbec, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c270t-ae6819f7c90aaa50108ec8f50049ab13f66d860dfd98970253aea50dd4ab57713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Antigens, CD - metabolism</topic><topic>Carcinoma - metabolism</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - secondary</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Prognosis</topic><topic>Receptors, Tumor Necrosis Factor - metabolism</topic><topic>Receptors, Tumor Necrosis Factor, Type I</topic><topic>Slovenia</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Galvani, V</creatorcontrib><creatorcontrib>Pretnar Hartman, K</creatorcontrib><creatorcontrib>Rupreht, R R</creatorcontrib><creatorcontrib>Novaković, S</creatorcontrib><creatorcontrib>Stabuc, B</creatorcontrib><creatorcontrib>Ocvirk, J</creatorcontrib><creatorcontrib>Menart, V</creatorcontrib><creatorcontrib>Gaberc Porekar, V</creatorcontrib><creatorcontrib>Stalc, A</creatorcontrib><creatorcontrib>Rozman, P</creatorcontrib><creatorcontrib>Curin Serbec, V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Calcium & Calcified Tissue Abstracts</collection><jtitle>Pflügers Archiv</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Galvani, V</au><au>Pretnar Hartman, K</au><au>Rupreht, R R</au><au>Novaković, S</au><au>Stabuc, B</au><au>Ocvirk, J</au><au>Menart, V</au><au>Gaberc Porekar, V</au><au>Stalc, A</au><au>Rozman, P</au><au>Curin Serbec, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population</atitle><jtitle>Pflügers Archiv</jtitle><addtitle>Pflugers Arch</addtitle><date>2000</date><risdate>2000</risdate><volume>440</volume><issue>5 Suppl</issue><spage>R61</spage><epage>R063</epage><pages>R61-R063</pages><issn>0031-6768</issn><eissn>1432-2013</eissn><abstract>Tumor necrosis factor alpha (TNF-alpha) and its receptors (TNFRI and TNFRII) which exist in soluble form as a product of cleavage of the extracellular domain of membrane integrated receptors, still rise debate about their importance. It was reported that TNF-alpha has numerous actions in diseases such as inflammation, autoimmunity, infectious diseases, septic shock and many types of cancer [1, 2]. Several authors have reported the significance of sTNFRI level in serum of cancer patients [3, 4]. This study was performed in collaboration with the Institute of Oncology of Slovenia. At least two different mouse monoclonal antibodies (MAbs) against human sTNFRI have been prepared to obtain a sensitive and reliable sandwich ELISA. It was compared with commercially available R&D and Endogen ELISAs for the determination of sTNFRI. Groups of patients with different stages of melanoma and epithelial ovarian carcinoma were tested and their clinical records were reexamined. Levels of sTNFRI were measured and compared with the normal serum levels of sTNFRI.</abstract><cop>Germany</cop><pmid>11005614</pmid><doi>10.1007/s004240000007</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-6768 |
| ispartof | Pflügers Archiv, 2000, Vol.440 (5 Suppl), p.R61-R063 |
| issn | 0031-6768 1432-2013 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72293627 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Antigens, CD - metabolism Carcinoma - metabolism Enzyme-Linked Immunosorbent Assay Female Humans Male Melanoma - metabolism Melanoma - secondary Ovarian Neoplasms - metabolism Prognosis Receptors, Tumor Necrosis Factor - metabolism Receptors, Tumor Necrosis Factor, Type I Slovenia Solubility |
| title | Soluble tumor necrosis factor receptor I (sTNFRI) as a prognostic factor in melanoma patients in Slovene population |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A50%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Soluble%20tumor%20necrosis%20factor%20receptor%20I%20(sTNFRI)%20as%20a%20prognostic%20factor%20in%20melanoma%20patients%20in%20Slovene%20population&rft.jtitle=Pfl%C3%BCgers%20Archiv&rft.au=Galvani,%20V&rft.date=2000&rft.volume=440&rft.issue=5%20Suppl&rft.spage=R61&rft.epage=R063&rft.pages=R61-R063&rft.issn=0031-6768&rft.eissn=1432-2013&rft_id=info:doi/10.1007/s004240000007&rft_dat=%3Cproquest_cross%3E1859471248%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1852781444&rft_id=info:pmid/11005614&rfr_iscdi=true |